Merck, GlaxoSmithKline halt copay help for Obamacare patients
27.03.2014 / Fierce Pharma
Merck and GlaxoSmithKline have nixed their copay assistance for Obamacare patients. The two companies say they fear subsidizing patients' drug purchases will run afoul of federal anti-kickbacks law. But many other top drugmakers- including Novartis, Sanofi and Eli Lilly–will keep their copay cards and discounts, at least for now.